VOLUME 10 (2019)
View Archive »
About The Cover
The cover for issue 35 of Oncotarget features Figure 8A (TOP PANEL), "Hep-2 cells were incubated with the indicated compounds in the presence of HSV1-Luc virus at a concentration of 4 X 106 pfu/ml media," and Figure 2A (BOTTOM PANEL), "Docked Model of RACK1A with SD-29 at the Y248 phosphorylation site," by Ullah, et al.
|
|
Table of Contents
Editorial
|
| Obesity: an heavyweight player in breast cancer’s chemoresistance |
|
https://doi.org/10.18632/oncotarget.26905
Charlotte Vaysse, Catherine Muller, Frédérique Fallone
|
| 3207-3208 |
Research Papers
|
| Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation |
|
https://doi.org/10.18632/oncotarget.26907
Hemayet Ullah, Wangheng Hou, Sivanesan Dakshanamurthy, Qiyi Tang
|
| 3209-3226 |
|
| Deregulated expression of NKL homeobox genes in T-cell lymphomas |
|
https://doi.org/10.18632/oncotarget.26929
Stefan Nagel, Claudia Pommerenke, Roderick A.F. MacLeod, Corinna Meyer, Maren Kaufmann, Silke Fähnrich, Hans G. Drexler
|
| 3227-3247 |
|
| Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.26933
Olga Gordeeva, Andrey Gordeev, Sergey Khaydukov
|
| 3248-3266 |
|
| A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research |
|
https://doi.org/10.18632/oncotarget.26938
Xiaoman Chen, Yulu Shi, Kaiwen Zhou, Sijie Yu, Wei Cai, Muying Ying
|
| 3267-3275 |
|
| Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X |
|
https://doi.org/10.18632/oncotarget.26852
Reiko Yoshida, Chie Watanabe, Shiro Yokoyama, Mayuko Inuzuka, Junko Yotsumoto, Masami Arai, Seigo Nakamura
|
| 3276-3284 |
|
| Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.26904
Ling Wang, Hung Lam, Yaping Shou, Aaron Galaznik
|
| 3285-3293 |
Reviews
|
| Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials |
|
https://doi.org/10.18632/oncotarget.26908
Alberto Carretero-González, David Lora, Ismael Ghanem, Irene Otero, Flora López, Daniel Castellano, Guillermo de Velasco
|
| 3294-3301 |
Case Reports
|
| Sustained partial remission of a metastatic NEN using offlabel immunotherapy with pembrolizumab |
|
https://doi.org/10.18632/oncotarget.26906
|
| 3302-3311 |
Corrections
|
| Correction: A keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer |
|
https://doi.org/10.18632/oncotarget.26962
Michael R. Evans, Claire D. James, Oonagh Loughran, Tara J. Nulton, Xu Wang, Molly L. Bristol, Brad Windle, Iain M. Morgan
|
| 3312-3312 |
|
| Correction: Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease |
|
https://doi.org/10.18632/oncotarget.26963
Lei Peng, Guanglin Chen, Zhongxian Zhu, Ziyang Shen, Chunxia Du, Rujin Zang, Yang Su, Hua Xie, Hongxing Li, Xiaoqun Xu, Yankai Xia, Weibing Tang
|
| 3313-3314 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
